Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03233152
Title Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma (GlitIpNi)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Universitair Ziekenhuis Brussel
Age Groups: adult | senior
Covered Countries BEL

No variant requirements are available.